Tesaro was founded by Mary Lynne Hedley, Leon O. Moulder, Jr..

Who are Tesaro's investors?

Tesaro's investors include New Enterprise Associates (NEA), Kleiner Perkins.

How much funding has Tesaro raised?

Tesaro has disclosed $205M raised across 2 rounds.

Where is Tesaro headquartered?

Tesaro is headquartered in London, GB.

Tesaro

London, GB · 2 known investors

gsk.com ↗

GSK is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients. Its research focuses on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.

BiotechHealthtech

Founders & leadership

Mary Lynne HedleyCo-founder

Leon O. Moulder, Jr.Co-founder

Jeffrey HankeExecutive

Joseph L. FarmerExecutive

Grant C. BogleExecutive

Martin H. HuberExecutive

Timothy R. PearsonExecutive

Emma Walmsleyin

Board

Beth Seidenberg in 𝕏Board directorFounding Managing Director at Westlake Village BioPartners

Arnold L. OronskyBoard director

Garry A. NicholsonBoard director

Lawrence AllevaBoard director

Investors · 2

New Enterprise Associates (NEA)Menlo Park · $200K – $40Mvia Kavita Patel · board

Kleiner PerkinsreportedMenlo Park · $500K – $15Mvia Beth Seidenberg · board

Reported raises · per SEC filings

Form D private placements

$205M disclosed across 2 rounds · 2016

▶$50MraisedApr 2016 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Grant C. BogleExecutive Officer
Timothy R. PearsonExecutive Officer
Leon O. Moulder, Jr.Executive Officer, Director
Mary Lynne HedleyExecutive Officer, Director
Jeffrey HankeExecutive Officer
Kavita PatelDirector
Lawrence AllevaDirector
Earl M. Collier, Jr.Director
Martin H. HuberExecutive Officer
Joseph L. FarmerExecutive Officer
James O. ArmitageDirector
Garry A. NicholsonDirector
David M. MottDirector
Beth SeidenbergDirector
Arnold L. OronskyDirector

Offering amount: $50M
Amount sold: $50M
First sale: Apr 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$155MraisedMar 2016 · 7 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Jeffrey HankeExecutive Officer
Joseph L. FarmerExecutive Officer
Grant C. BogleExecutive Officer
Garry A. NicholsonDirector
Lawrence AllevaDirector
Beth SeidenbergDirector
Mary Lynne HedleyExecutive Officer, Director
Arnold L. OronskyDirector
Martin H. HuberExecutive Officer
James O. ArmitageDirector
Timothy R. PearsonExecutive Officer
Leon O. Moulder, Jr.Executive Officer, Director
David M. MottDirector
Earl M. Collier, Jr.Director

Offering amount: $155M
Amount sold: $155M
First sale: Feb 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Tesaro do?: GSK is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients. Its research focuses on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.
Who founded Tesaro?: Tesaro was founded by Mary Lynne Hedley, Leon O. Moulder, Jr..
Who are Tesaro's investors?: Tesaro's investors include New Enterprise Associates (NEA), Kleiner Perkins.
How much funding has Tesaro raised?: Tesaro has disclosed $205M raised across 2 rounds.
Where is Tesaro headquartered?: Tesaro is headquartered in London, GB.